iMedix Medical Content Engine 3.13.37

Hello,

Sign up to join our community!

Welcome Back,

Please sign in to your account!

Forgot Password,

Lost your password? Please enter your email address. You will receive a link and will create a new password via email.

Sorry, you do not have permission to ask a question, You must login to ask a question.

iMedix Is Now Available for Acquisition

A Legendary Global Digital Health Asset with a 20-Year Legacy

This is a rare opportunity to acquire a project that didn’t just survive the digital health evolution — it helped shape it.

iMedix is a globally recognized digital health platform with proven market value, corporate credibility, and ready-to-scale infrastructure built for international growth.


What is iMedix?

iMedix is not just another health portal. It’s a fully integrated digital ecosystem, developed and refined over two decades — earning the trust of millions of users across the US, Europe, and Asia.

Core Strengths of the Asset:

🟢 A Global Brand
The premium domain iMedix.com and a name recognized worldwide — this level of brand equity cannot be bought or rebuilt overnight.

🟢 Unmatched SEO Capital
Thousands of optimized pages ranking high on Google in one of the world’s most competitive verticals — healthcare — ensuring consistent, high-intent organic traffic.

🟢 Robust Technological Infrastructure
Fast, secure, and flexible architecture managed through a streamlined CMS — ready for scaling without needing a rebuild.

🟢 Structured Knowledge Base
A comprehensive system with categorized modules:
Drugs, Diseases, Doctors, Pharmacies, Blog, News, and Questions — all seamlessly connected.


Verified Value and Industry Recognition

⭐️ In 2008, PCWorld named iMedix one of the “100 Most Useful and Interesting Websites” — a testament to its relevance and user value from the very beginning.
⭐️ In 2011, the platform was acquired by AVG Technologies, a global software leader, for integration into its healthcare solutions — a powerful endorsement of iMedix’s strategic value and system architecture.


Why Are We Selling?

iMedix has evolved from a startup to a recognized brand, was once part of a global software corporation, and is now back under independent ownership. Our current strategic focus has shifted toward new ventures, and we believe the time is right for a new operator to take over.

This is a strategic transition, designed to place the asset in the hands of a new owner with the resources and vision to unlock its next stage of growth.


Why iMedix Is a One-of-a-Kind Investment

🔷 Low Risk, High Value
This isn’t a beta project or idea-stage startup. It’s a mature, operational platform with validated traffic, real-world use, and a technical foundation already in place.

🔷 Brand Trust & Authority
Two decades of visibility, authority, and user trust across global markets.

🔷 Unlimited Monetization Potential
Ready to support everything from pharma partnerships and marketplace integrations to telemedicine services, subscriptions, and digital advertising.

🔷 Scalable Without Rebuilding
You don’t need to redesign or re-architect. iMedix is built for growth — just plug in your vision.


What’s Included in the Sale:

✔️ The iMedix.com domain and full trademark rights
✔️ The complete codebase and technology infrastructure
✔️ Full content and database (structure, articles, media assets)
✔️ SEO systems and all editorial assets
✔️ All official social media accounts
✔️ Full admin access to the CMS
✔️ Transition support and consultation from the current team


🔗 Access Full Project Details

Want to receive the confidential investment deck, traffic analytics, and discuss acquisition terms?
👉 Fill out the contact form — and we’ll contact you directly to provide everything you need.

iMedix Editorial Team

The iMedix Editorial Team is dedicated to delivering accurate, evidence-based medical information. We enforce strict quality standards to ensure all content aligns with current clinical protocols and regulatory safety guidance. Our goal is to empower readers with reliable educational data, not to provide personal medical advice.